Valeant Pharmaceuticals International v. Jerney
Delaware Court of Chancery
921 A.2d 732 (2007)
Valeant Pharmaceuticals International (plaintiff) planned to spin off one of its assets, creating a new company. Valeant planned an initial public offering (IPO) for the spinoff. As part of the spinoff, the Valeant board of directors planned to award themselves bonuses. Valeant had an operating income of $189 million. Milan Panic, Valeant’s Chairman and CEO, proposed bonuses for the directors valued at a total of approximately $50 million. The issue of the bonuses was referred to Valeant’s compensation committee, which consisted of three directors, each of whom stood to receive the bonus under consideration. Furthermore, two of those directors had a longstanding personal friendship with Panic and had discussed potential consulting jobs with Panic. The committee did not hire an independent consultant to review the plan, but rather, at the direction of the board, hired Towers Perrin, a group that had previously determined for the board that the proposed bonuses were justified. The resulting Tower Perrin report concluded that the bonuses were fair. Just before the IPO, the board was informed that it would need to be re-priced, down from $13 to $15 per share, to $10 per share. Panic was advised by Valeant’s counsel that the bonuses should be revisited in light of this change. Panic ignored this advice, and the board approved the new IPO price but did not re-address the bonuses. In the end, Panic received a cash bonus of almost $30 million. Adam Jerney (defendant), a former director and president of Valeant received $3 million. Jerney voted in favor of the bonuses. Panic had domineered the entire process leading up to the approval of the bonuses. Shareholders brought a shareholder derivative suit to challenge the bonuses and the process that led to them. Valeant eventually took control of the suit. All defendant-directors settled, except for Jerney.
Rule of Law
Holding and Reasoning (Lamb, J.)
What to do next…
Unlock this case brief with a free (no-commitment) trial membership of Quimbee.
You’ll be in good company: Quimbee is one of the most widely used and trusted sites for law students, serving more than 726,000 law students since 2011. Some law schools—such as Yale, Berkeley, and Northwestern—even subscribe directly to Quimbee for all their law students.Unlock this case briefRead our student testimonials
Learn more about Quimbee’s unique (and proven) approach to achieving great grades at law school.
Quimbee is a company hell-bent on one thing: helping you get an “A” in every course you take in law school, so you can graduate at the top of your class and get a high-paying law job. We’re not just a study aid for law students; we’re the study aid for law students.Learn about our approachRead more about Quimbee
Here's why 726,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 45,700 briefs, keyed to 983 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.